The United States will not impose an ad valorem tariff on certain speciality drugs and related ingredients imported from India, even as Washington prepares to levy a 100% tariff on specified patented pharmaceutical products from September 29, PTI reported on Monday.
An ad valorem tariff is a tax charged as a fixed percentage of the monetary value of imported goods.